Market Tracker

10/17 6:35pm ET

Rosetta Genomics Ltd (NASDAQ:ROSG)

3.00
Data as of Oct 17
 -0.13 / -4.15%
Today’s Change
2.35
Today|||52-Week Range
6.69
+2.74%
Year-to-Date

Today’s Trading

Previous close3.13
Today’s open3.16
Day’s range3.00 - 3.16
Volume24,589
Average volume (3 months)77,767
Market cap$35.1M
Dividend yield--
Data as of 3:59pm ET, 10/17/2014

Growth & Valuation

Earnings growth (last year)+42.98%
Earnings growth (this year)+20.63%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+101.49%
P/E ratio--
Price/Sales69.17
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
SNGXSoligenix Inc+0.05+2.99%
--EnzymeBioSystems0.000.00%
CRMDCorMedix Inc-0.06-3.87%
--BioPharmX Corp0.000.00%
Data as of 3:59pm ET, 10/17/2014

Financials

Last reporting dateNovember 7, 2013
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$405.0K
Annual profit (last year)-$12.9M
Net profit margin-3,251.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Head-Investor Relations
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, --

Forecasts